Joseph M Miller, Director at Avalo Therapeutics, holds 495.93K shares in Aurinia Pharmaceuticals (Ticker: AUPH), holds 40.58K shares in Avalo Therapeutics (Ticker: AVTX). Most recently, Joseph M Miller Sold ― shares of Aurinia Pharmaceuticals on Mar 07, 2024 for an estimated value of 194.94K.